Utopia SIS S.p.A.

Overview

Utopia SIS S.p.A. is a venture capital firm based in Bologna, Italy, focusing on life sciences startups. The firm aims to bridge the gap between the perception of collective well-being and its actual implementation by investing in high-growth projects in the medical-scientific field. By investing in these startups and focusing efforts on the Life Sciences sector, Utopia seeks to revitalize the investment landscape and promote genuine well-being in the economy. The firm specializes in Seed and Series A investments in areas such as disease-modifying drugs, cross-border applications with artificial intelligence, medical devices, and diagnostic tools and biomarkers. Utopia's portfolio includes companies like Novavido Srl, PerFormS Srl, Lighthouse Biotech Srl, Drug Discovery and Clinic Srl, CaSRevolution Srl, and T-One Therapeutics Srl. Utopia was established with the aim of bridging the gap between the perception of collective well-being and its actual implementation in reality. The startups of the future are those that pursue collective well-being throughout the value chain. By investing in these startups and focusing efforts on the Life Sciences sector, Utopia believes it can give a new impetus to the future of investments and the pursuit of collective well-being in the real economy. The business of the future is collective well-being, and the goal is certainly challenging, but if it weren’t, Utopia would have certainly chosen a different name. The firm is promoted and owned by the Golinelli Foundation, with a team comprising professionals with complementary expertise in the Life Sciences sector and venture capital. The team includes CEO Antonio Falcone, Scientific Venture Partner Sergio Abrignani, Risk Manager Rodolfo Quagliuolo, and Financial Analyst Emanuele D'Erme. The board of directors includes Stefano Cattorini (President), Sergio Abrignani, Giacomo Spissu, Rodolfo Quagliuolo, Antonio Falcone, Antonio Danieli, and Giampaolo Girotti. The scientific advisory board includes Andrea Ballabio, Antonio Lanzavecchia, and Pier Giuseppe Pelicci. Utopia operates as a Società di Investimento Semplice (SIS), a venture capital vehicle aimed at investing in start-ups and unlisted SMEs, subject to a subsidized regime. The firm is registered with the Italian Business Register (REA) under number BO – 556832 and is listed with number 45 in the register of SICAFs (Collective Investment Companies) under Article 35 of the Consolidated Law on Finance (TUF).